Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 3046 AL 3060

Alzheimer's Disease and its Related Dementia Types: A Review on Their Management Via Nanotechnology Based Therapeutic Strategies

Siafaka PI, Mutlu G, Okur NÜ.

Curr Alzheimer Res. 2020;17(14):1239-1261. doi: 10.2174/1567205018666210218160812.

CAR (Current Alzheimer Research) has a ROAD (Research on AD) Even in the Lockdown

Lahiri DK, Farlow MR.

Curr Alzheimer Res. 2020;17(12):1053-1054. doi: 10.2174/156720501712210222105659.

Alzheimer's disease: exploring nature's 'medicinal chest' for new therapeutic agents

Tsarbopoulos A.

Biomol Concepts. 2020 Dec 23;11(1):201-208. doi: 10.1515/bmc-2020-0018.

Alzheimer's disease: A need for personalized therapeutic approaches

Frenkel D.

Drug Dev Res. 2020 Apr;81(2):141-143. doi: 10.1002/ddr.21652. Epub 2020 Mar 3.

Traditional Chinese medicine Danggui Shaoyao San for the treatment of Alzheimer's disease: A Protocol for Systematic Review

You Y, Liu X, You Y, Liu D, Zhang C, Chen Y, Zhang T.

Medicine (Baltimore). 2020 Apr;99(15):e19669. doi: 10.1097/MD.0000000000019669.

Acupuncture therapy for Alzheimer's disease: A protocol for an overview of systematic reviews

Wang L, Xu J, Zhan Y, Pei J.

Medicine (Baltimore). 2020 May 22;99(21):e20244. doi: 10.1097/MD.0000000000020244.

Preclinical Alzheimer Disease Drug Development: Early Considerations Based on Phase 3 Clinical Trials

Hung A, Schneider M, Lopez MH, McClellan M.

J Manag Care Spec Pharm. 2020 Jul;26(7):888-900. doi: 10.18553/jmcp.2020.26.7.888.

Hospital incidence, mortality and costs of Alzheimer's disease in Spain: a retrospective multicenter study

Darbà J, Marsà A.

Expert Rev Pharmacoecon Outcomes Res. 2021 Oct;21(5):1101-1106. doi: 10.1080/14737167.2020.1820328. Epub 2020 Sep 14.

[Position paper of the Austrian Alzheimer Association (Österreichische Alzheimer Gesellschaft, ÖAG) : Effects of the COVID-19 pandemic in Austria on people with dementia and their care environment-problem areas, recommendations, and strategies]

Defrancesco M, Bancher C, Dal-Bianco P, Hinterhuber H, Schmidt R, Struhal W, Ransmayr G, Stögmann E, Marksteiner J.

Neuropsychiatr. 2021 Mar;35(1):35-47. doi: 10.1007/s40211-020-00363-9. Epub 2020 Oct 29.

Suboptimal validity of amyloid imaging-based diagnosis and management of Alzheimer's disease: why it is time to abandon the approach

Alavi A, Barrio JR, Werner TJ, Khosravi M, Newberg A, Høilund-Carlsen PF.

Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):225-230. doi: 10.1007/s00259-019-04564-5.

Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer's disease

Sabbagh M, Sadowsky C, Tousi B, Agronin ME, Alva G, Armon C, Bernick C, Keegan AP, Karantzoulis S, Baror E, Ploznik M, Pascual-Leone A.

Alzheimers Dement. 2020 Apr;16(4):641-650. doi: 10.1016/j.jalz.2019.08.197. Epub 2020 Jan 16.

An Exploratory Phase IIa Study of the PPAR delta/gamma Agonist T3D-959 Assessing Metabolic and Cognitive Function in Subjects with Mild to Moderate Alzheimer's Disease

Chamberlain S, Gabriel H, Strittmatter W, Didsbury J.

J Alzheimers Dis. 2020;73(3):1085-1103. doi: 10.3233/JAD-190864.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias